Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Kush Parmar10% Owner | Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/15 | 2,941,176 sh | $1.53 | $4,499,999.28 | No record |
5AM Ventures VI10% Owner | Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/15 | 2,941,176 sh | $1.53 | $4,499,999.28 | No record |
5AM Partners VI10% Owner | Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/15 | 2,941,176 sh | $1.53 | $4,499,999.28 | No record |
5AM Opportunities II10% Owner | Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/15 | 2,941,176 sh | $1.53 | $4,499,999.28 | No record |
5AM Ventures VII10% Owner | Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/15 | 2,941,176 sh | $1.53 | $4,499,999.28 | No record |
5AM Opportunities II10% Owner | Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/15 | 2,941,176 sh | $1.53 | $4,499,999.28 | No record |
5AM Partners VII10% Owner | Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/15 | 2,941,176 sh | $1.53 | $4,499,999.28 | No record |
Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/11 | 1,307,189 sh2 trades | $1.53avg. | $1,999,999.17 | No record | |
Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/11 | 1,307,189 sh2 trades | $1.53avg. | $1,999,999.17 | No record | |
Richard A. YoungDirector | Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/11 | 15,151 sh | $1.65 | $24,999.15 | +9.8% |
Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/11 | 1,307,189 sh2 trades | $1.53avg. | $1,999,999.17 | No record | |
Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/11 | 1,307,189 sh2 trades | $1.53avg. | $1,999,999.17 | No record | |
Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/11 | 1,307,189 sh2 trades | $1.53avg. | $1,999,999.17 | No record | |
Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/11 | 1,307,189 sh2 trades | $1.53avg. | $1,999,999.17 | No record | |
Yuri MaricichChief Medical Officer | Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/11 | 6,060 sh | $1.65 | $9,999 | No record |
Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/11 | 1,307,189 sh2 trades | $1.53avg. | $1,999,999.17 | No record | |
Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/11 | 1,307,189 sh2 trades | $1.53avg. | $1,999,999.17 | No record | |
Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/11 | 6,060 sh | $1.65 | $9,999 | +2.2% | |
Kelly GoldCFO | Camp4 TherapeuticsCAMP | Open-market buy | 25/09/11 | 25/09/11 | 6,060 sh | $1.65 | $9,999 | +9.8% |
Brian Chee10% Owner | Camp4 TherapeuticsCAMP | Open-market buyAmendment | 24/10/15 | 24/10/22 | 909,090 sh | $11.00 | $9,999,990 | No record |
